"Say Ninetynine": It's Never too Late to Recover from COVID-19.
Frailty
aging
comprehensive geriatric assesment
covid-19
Journal
The Journal of frailty & aging
ISSN: 2260-1341
Titre abrégé: J Frailty Aging
Pays: France
ID NLM: 101604797
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
17
12
2020
pubmed:
18
12
2020
medline:
22
12
2020
Statut:
ppublish
Résumé
COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, showed higher severity and lethality in male older adults . There are currently no specific treatments. Studies are evaluating the efficacy of monoclonal antibodies against interleukin-6 receptor. Here we present the case of a 98-years old man admitted to our COVID-Hospital with acute respiratory failure. Comprehensive geriatric assessment showed no signs of frailty. First-line therapy with hydroxychloroquine and anticoagulants was not effective. Patient was administered intravenous monoclonal antibodies, and he showed remarkable clinical improvement. This case suggests that age alone should not preclude access to new therapeutic approaches. Comprehensive, multisciplinary, multidomain approaches are needed to develop patient-tailored treatments against COVID-19.
Identifiants
pubmed: 33331625
doi: 10.14283/jfa.2020.41
pmc: PMC7412775
doi:
Substances chimiques
Antibodies, Monoclonal
0
IL6R protein, human
0
Immunoglobulins, Intravenous
0
Receptors, Interleukin-6
0
Hydroxychloroquine
4QWG6N8QKH
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
70-71Déclaration de conflit d'intérêts
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Références
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Chest. 2020 Jul;158(1):97-105
pubmed: 32304772
J Nutr Health Aging. 2020;24(5):466-470
pubmed: 32346682